Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 27, 2021 15:02 ET | Source: ClearPoint Neuro, Inc.

ClearPoint Neuro, Inc. kündigt Erweiterung seines Teams für die präklinische und translationale Entwicklung zur Unterstützung seiner Partner im Bereich Gen- und Stammzelltherapien an

IRVINE, Kalifornien, Jan. 27, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT), ein weltweit tätiges Unternehmen, das Neuronavigationssysteme für die Durchführung von Eingriffen am...
January 27, 2021 15:02 ET | Source: ClearPoint Neuro, Inc.

ClearPoint Neuro, Inc. annonce l'expansion de son équipe de développement préclinique et translationnel afin de soutenir ses partenaires spécialisés dans la thérapie génique et le traitement à base de cellules souches

IRVINE, Californie, 27 janv. 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq : CLPT), une société mondiale de plateforme de traitement permettant la navigation et l'acheminement au cerveau,...
January 26, 2021 16:05 ET | Source: ClearPoint Neuro, Inc.

ClearPoint Neuro, Inc. Announces Expansion of Pre-Clinical and Translational Development Team to Support Gene and Stem Cell Therapy Partners

IRVINE, Calif., Jan. 26, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced...
January 15, 2021 11:50 ET | Source: ClearPoint Neuro, Inc.

ClearPoint Neuro, Inc. gibt ersten Eingriff mit ClearPoint® 2.0 Software in Europa bekannt

IRVINE, Kalifornien, Jan. 15, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT), ein weltweit tätiges Unternehmen, das Neuronavigationssysteme für die Durchführung von Eingriffen am...
January 15, 2021 11:50 ET | Source: ClearPoint Neuro, Inc.

ClearPoint Neuro, Inc. annonce la première intervention utilisant le logiciel ClearPoint® 2.0 en Europe

IRVINE, Californie, 15 janv. 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq : CLPT), une société mondiale de plateforme de traitement permettant la navigation et l'acheminement au cerveau,...
January 14, 2021 16:05 ET | Source: ClearPoint Neuro, Inc.

ClearPoint Neuro, Inc. Announces First Procedure Utilizing ClearPoint® 2.0 Software in Europe

IRVINE, Calif., Jan. 14, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT), a global therapy-enabling platform company providing navigation and delivery to the brain, today reported the...
January 12, 2021 16:05 ET | Source: ClearPoint Neuro, Inc.

ClearPoint Neuro, Inc. Reports Record Revenue in Preliminary Fourth Quarter 2020 Results

IRVINE, Calif., Jan. 12, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain,...
December 29, 2020 16:15 ET | Source: ClearPoint Neuro, Inc.

ClearPoint Neuro, Inc. Announces Funding of Additional $7.5M of Existing Convertible Note on Improved Terms

IRVINE, Calif., Dec. 29, 2020 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain,...
November 30, 2020 09:15 ET | Source: ClearPoint Neuro, Inc.

ClearPoint Neuro Completes 4,000th ClearPoint® Neuro Navigation Procedure

IRVINE, Calif., Nov. 30, 2020 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT), a leader in image-guided stereotactic neurosurgery, announced that its 4,000th neurosurgical procedure using...
November 10, 2020 16:05 ET | Source: ClearPoint Neuro, Inc.

ClearPoint Neuro Reports Third Quarter 2020 Results

IRVINE, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT), a medical device company with a portfolio of products focused on enabling therapies for neurological...